20826-04-4 | 5-Bromonicotinic acid

Packsize	Purity	Availability	Price	Discounted Price
25g	98%	in stock	$13.00	$9.00
100g	98%	in stock	$33.00	$23.00
1kg	98%	in stock	$285.00	$200.00
5kg	98%	in stock	$1,291.00	$904.00

Description

• Catalog Number: AB18521
• Chemical Name: 5-Bromonicotinic acid
• CAS Number: 20826-04-4
• Molecular Formula: C6H4BrNO2
• Molecular Weight: 202.00545999999994
• MDL Number: MFCD00009783
• SMILES: OC(=O)c1cc(Br)cnc1
• NSC Number: 9461

Computed Properties

• Complexity: 140
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 10
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 1
• XLogP3: 1.1

Literature

• Exceptional crystallization diversity and solid-state conversions of Cd(II) coordination frameworks with 5-bromonicotinate directed by solvent media.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20120924

• 2-(5-Bromo-pyridin-3-yl)-5-[3-(4,5,6,7-tetra-hydro-thieno[3,2-c]pyridine-5-ylsulfon-yl)thio-phen-2-yl]-1,3,4-oxa-diazole.

  Acta crystallographica. Section E, Structure reports online 20111001

• Tetra-kis(μ-5-bromo-nicotinato)-κO,O':O';κO:O,O';κO:O'-bis-[diaqua-(5-bromo-nicotinato-κO,O')neodymium(III)] dihydrate.

  Acta crystallographica. Section E, Structure reports online 20110701

• catena-Poly[[bis-(μ-5-bromo-pyridine-3-carboxyl-ato-κO:O')dicopper(II)]-bis-(μ-5-bromo-pyridine-3-carboxyl-ato)-κO,O':N;κN:O,O'].

  Acta crystallographica. Section E, Structure reports online 20101101

• Poly[(μ(3)-5-bromo-nicotinato)(5-bromo-nicotinato)copper(II)].

  Acta crystallographica. Section E, Structure reports online 20091001

• catena-Poly[[(5-bromopyridine-3-carbox-yl-ato)dimetyltin(IV)]-μ-5-bromopyridine-3-carboxyl-ato].

  Acta crystallographica. Section E, Structure reports online 20080101

• Agonist lead identification for the high affinity niacin receptor GPR109a.

  Bioorganic & medicinal chemistry letters 20070901

• Unusual sterically controlled regioselective lithiation of 3-bromo-5-(4,4'-dimethyl)oxazolinylpyridine. Straightforward access to highly substituted nicotinic acid derivatives.

  Organic letters 20061221

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Radiobromination of humanized anti-HER2 monoclonal antibody trastuzumab using N-succinimidyl 5-bromo-3-pyridinecarboxylate, a potential label for immunoPET.

  Nuclear medicine and biology 20050801

• Functional diversity among 5-substituted nicotine analogs; in vitro and in vivo investigations.

  European journal of pharmacology 20020125